Abstract： Macular foveoschisis is one of the most common complications of high myopic posterior scleral staphyloma. This article will introduce the mechanism, pathological changes, associated diseases, natural evolution and operative treatments of high myopic foveoschisis.
Shinohara K, Tanaka N, Jonas JB, et al. Ultrawide-field OCT to investigate relationships between myopic macular retinoschisis and posterior staphyloma. Ophthalmology, 2018, 125(10): 1575- 1586. DOI: 10.1016/j.ophtha.2018.03.053.
[2]
García-Ben A, Blanco MJ, Piñeiro A, et al. Relationship between macular bending and foveoschisis in myopic patients. Optom Vis Sci, 2014, 91(5): 497-506. DOI: 10.1097/ OPX.0000000000000250.
[3]
Chen L, Wei Y, Zhou X, et al. Morphologic, biomechanical, and compositional features of the internal limiting membrane in pathologic myopic foveoschisis. Invest Ophthalmol Vis Sci, 2018, 59(13): 5569-5578. DOI: 10.1167/iovs.18-24676.
[4]
Xiao W, Zhu Z, Odouard C, et al. Wide-field en face sweptsource optical coherence tomography features of extrafoveal retinoschisis in highly myopic eyes. Invest Ophthalmol Vis Sci, 2017, 58(2): 1037-1044. DOI: 10.1167/iovs.16-20607.
Shimada N, Tanaka Y, Tokoro T, et al. Natural course of myopic traction maculopathy and factors associated with progression or resolution. Am J Ophthalmol, 2013, 156(5): 948-957. DOI: 10.1016/j.ajo.2013.06.031.
[7]
Lai TT, Ho TC, Yang CM. Spontaneous resolution of foveal detachment in traction maculopathy in high myopia unrelated to posterior vitreous detachment. BMC Ophthalmol, 2016, 16: 18. DOI: 10.1186/s12886-016-0195-3.
[8]
Yasushi Ikuno. Overview of the complications of high myopia. Retina (Philadelphia, Pa.), 2017, 37(12): 2347-2351. DOI: 10.1097/IAE.0000000000001489.
[9]
Lichtwitz O, Boissonnot M, Mercié M, et al. Prevalence of macular complications associated with high myopia by multimodal imaging. J Fr Ophtalmol, 2016, 39(4): 355-363. DOI: 10.1016/j.jfo.2015.11.005.
[10]
Benhamou N, Massin P, Haouchine B, et al. Macular retinoschisis in highly myopic eyes. Am J Ophthalmol, 2002, 133(6): 794-800. DOI: 10.1016/s0002-9394(02)01394-6.
[11]
Sun CB, Liu Z, Xue AQ, et al. Natural evolution from macular retinoschisis to full-thickness macular hole in highly myopic eyes. Eye (Lond), 2010, 24(12): 1787-1791. DOI: 10.1038/ eye.2010.123.
[12]
Huang Y, Huang W, Ng DSC, et al. Risk factors for developmentof macular hole retinal detachment after pars plana vitrectomy for pathologic myopic foveoschisis. Retina (Philadelphia, Pa.), 2017, 37(6): 1049-1054. DOI:10.1097/IAE.0000000000001322.
Ohno-Matsui K, Ikuno Y, Lai T, et al. Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia. Prog Retin Eye Res, 2018, 63: 92-106. DOI: 10.1016/j.preteyeres.2017.10.005.
[15]
Gaucher D, Haouchine B, Tadayoni R, et al. Long-term followup of high myopic foveoschisis: Natural course and surgical outcome. Am J Ophthalmol, 2007, 143(3): 455-462. DOI: 10.1016/j.ajo.2006.10.053.
[16]
Hoang QV, Chen CL, Garcia-Arumi J, et al. Radius of curvature changes in spontaneous improvement of foveoschisis in highly myopic eyes. Br J Ophthalmol, 2016, 100(2): 222-226. DOI: 10.1136/bjophthalmol-2015-306628.
[17]
García-Ben A, García-Campos JM, Morillo Sanchez MJ, et al. Chorioretinal atrophy after spontaneous resolution of myopic foveoschisis. Case Rep Ophthalmol Med, 2014, 2014: 825906. DOI: 10.1155/2014/825906.
[18]
Hirota K, Hirakata A, Inoue M. Dehiscence of detached internal limiting membrane in eyes with myopic traction maculopathy with spontaneous resolution. BMC Ophthalmol, 2014, 14(39). DOI: 10.1186/1471-2415-14-39.
[19]
Iwasaki M, Miyamoto H, Okushiba U, et al. Fovea-sparing internal limiting membrane peeling versus complete internal limiting membrane peeling for myopic traction maculopathy. Jpn J Ophthalmol, 2020, 641(1). DOI: 10.1007/s10384-019- 00696-1.
[20]
Shinohara K, Shimada N, Takase H, et al. Functional and structural outcomes after fovea-sparing internal limiting membrane peeling for myopic macular retinoschisis by microperimetry. Retina (Philadelphia, Pa.), 2020, 408(8): 1500- 1511. DOI: 10.1097/IAE.0000000000002627.
[21]
Rizzo S, Giansanti F, Finocchio L, et al. Vitrectomy with internal limiting membrane peeling and air tamponade for myopic foveoschisis. Retina (Philadelphia, Pa.), 2019, 39(11): 2125-2131. DOI: 10.1097/IAE.0000000000002265.
[22]
Lehmann M, Devin F, Rothschild PR, et al. Preoperative factors influencing visual recovery after vitrectomy for myopic foveoschisis. Retina, 2019, 39(3): 594-600. DOI: 10.1097/ IAE.0000000000001992.
[23]
Laviers H, Li JO, Grabowska A, et al. The management of macular hole retinal detachment and macular retinoschisis in pathological myopia; a UK collaborative study. Eye (Lond), 2018, 32(11): 1743-1751. DOI: 10.1038/s41433-018-0166-4.
[24]
Lim LS, Ng WY, Wong D, et al. Prognostic factor analysis of vitrectomy for myopic foveoschisis. Br J Ophthalmol, 2015, 99(12): 1639-1643. DOI: 10.1136/bjophthalmol-2015-306885.
[25]
Zhang Z, Wei Y, Jiang X, et al. Pars plana vitrectomy and wide internal limiting membrane peeling with perfluoropropane tamponade for highly myopic foveoschisis-associated macular hole. Retina, 2017, 37(2): 274-282. DOI: 10.1097/ IAE.0000000000001146.
[26]
Shimada N, Ohno-Matsui K, Baba T, et al. Natural course of macular retinoschisis in highly myopic eyes without macular hole or retinal detachment. Am J Ophthalmol, 2006, 142(3): 497-500. DOI: 10.1097/IAE.0000000000001927.
[27]
Sun Z, Gao H, Wang M, et al. Rapid progression of foveomacular retinoschisis in young myopics. Retina, 2019, 39(7): 1278-1288. DOI: 10.1097/IAE.0000000000002203.
[28]
Jiang X, Zhang S, Zhang Z, et al. Comparative study of 27-gauge versus 25-gauge vitrectomy with air tamponade in the treatment of myopic foveoschisis. Ophthalmic Surg Lasers Imaging Retina, 2018, 49(10): e135-e142. DOI: 10.3928/23258160-20181002-16.
Meng B, Zhao L, Yin Y, et al. Internal limiting membrane peeling and gas tamponade for myopic foveoschisis: A systematic review and meta-analysis. BMC Ophthalmol, 2017, 17(1): 166. DOI: 10.1186/s12886-017-0562-8.
[31]
Morescalchi F, Russo A, Bahja H, et al. Fovea-sparing versus complete internal limiting membrane peeling in vitrectomy for the treatment of macular hole. Retina (Philadelphia, Pa.), 2020, 407(7): 1306-1314. DOI: 10.1097/IAE.0000000000002612.
[32]
Jiang J, Yu X, He F, et al. Treatment of myopic foveoschisis with air versus perfluoropropane: A retrospective study. Med Sci Monit, 2017, 23: 3345-3352. DOI: 10.12659/msm.901758.
[33]
Yun LN, Xing YQ. Long-term outcome of highly myopic foveoschisis treated by vitrectomy with or without gas tamponade. Int J Ophthalmol, 2017, 10(9): 1392-1395. DOI: 10.18240/ijo.2017.09.10.
[34]
Yao Y, Qu J, Dong C, et al. The impact of extent of internal limiting membrane peeling on anatomical outcomes of macular hole surgery: results of a 54-week randomized clinical trial. Acta Ophthalmol, 2019, 97(3): 1-10. DOI: 10.1111/aos.13853.
[35]
Chen SN. Large semicircular inverted internal limiting membrane flap in the treatment of macular hole in high myopia. Graefes Arch Clin Exp Ophthalmol, 2017, 255(12): 2337-2345. DOI: 10.1007/s00417-017-3808-5.
[36]
Wakabayashi T, Ikuno Y, Shiraki N, et al. Inverted internal limiting membrane insertion versus standard internal limiting membrane peeling for macular hole retinal detachment in high myopia: One-year study. Graefes Arch Clin Exp Ophthalmol, 2018, 256(8): 1387-1393. DOI: 10.1007/s00417-018-4046-1.
[37]
Alkabes M, Pichi F, Nucci P, et al. Anatomical and visual outcomes in high myopic macular hole (HM-MH) without retinal detachment: A review. Graefes Arch Clin Exp Ophthalmol, 2014, 252(2): 191-199. DOI: 10.1007/s00417-013- 2555-5.
[38]
Alkabes M, Burés-Jelstrup A, Salinas C, et al. Macular buckling for previously untreated and recurrent retinal detachment due to high myopic macular hole: A 12-month comparative study.Graefes Arch Clin Exp Ophthalmol, 2014, 252(4): 571-581. DOI: 10.1007/s00417-013-2497-y.
[39]
Burés-Jelstrup A, Alkabes M, Gómez-Resa M, et al. Visual and anatomical outcome after macular buckling for macular hole with associated foveoschisis in highly myopic eyes. Br J Ophthalmol, 2014, 98(1): 104-109. DOI: 10.1136/ bjophthalmol-2013-304016.
Ji X, Wang J, Zhang J, et al. The effect of posterior scleral reinforcement for high myopia macular splitting. J Int Med Res, 2011, 39(2): 662-666. DOI: 10.1177/147323001103900236.
[42]
Zhu SQ, Pan AP, Zheng LY, et al. Posterior scleral reinforcement using genipin-cross-linked sclera for macular hole retinal detachment in highly myopic eyes. Br J Ophthalmol, 2018, 102(12): 1701-1704. DOI: 10.1136/bjophthalmol-2017-311340.
[43]
Fujikawa M, Kawamura H, Kakinoki M, et al. Scleral imbrication combined with vitrectomy and gas tamponade for refractory macular hole retinal detachment associated with high myopia. Retina, 2014, 34(12): 2451-2457. DOI: 10.1097/ IAE.0000000000000246.
[44]
Raczyńska D, Lipowski P, Zorena K, et al. Enzymatic vitreolysis with recombinant tissue plasminogen activator for vitreomacular traction. Drug Des Devel Ther, 2015, 9: 6259-6268. DOI: 10.2147/DDDT.S88361.
[45]
Shinohara K, Yoshida T, Liu H, et al. Establishment of novel therapy to reduce progression of myopia in rats with experimental myopia by fibroblast transplantation on sclera. J Tissue Eng Regen Med, 2018, 12(1): e451-e461. DOI: 10.1002/ term.2275.
[46]
Rong S, Wang C, Han B, et al. Iontophoresis-assisted accelerated riboflavin/ultraviolet A scleral cross-linking: A potential treatment for pathologic myopia. Exp Eye Res, 2017, 162: 37-47. DOI: 10.1016/j.exer.2017.07.002.
浙公网安备 33030202001892号